FCH
ICPT

Freestone Capital Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Freestone Capital Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30
Closed -$1.24K – 1335
2020
Q3 		$1.24K Buy
+30
New +$1.38K ﹤0.01% 1094

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Freestone Capital Holdings's ICPT Position: Q4 2020 in Review

Freestone Capital Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 30 shares — an estimated $1.24K sold.

Freestone Capital Holdings first reported a position in ICPT in Q3 2020 and held it in 1 quarter. The position peaked at $1.24K in Q3 2020. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Freestone Capital Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Freestone Capital Holdings sold 30 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.24K.
  • Freestone Capital Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Freestone Capital Holdings's Intercept Pharmaceuticals, Inc. position peaked at $1.24K in Q3 2020.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Freestone Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.